Suicidality in clinically stable bipolar disorder and schizophrenia patients during the COVID-19 pandemic.
Transl Psychiatry
; 12(1): 303, 2022 07 29.
Article
in English
| MEDLINE | ID: covidwho-1967593
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has a disproportionate impact on vulnerable subpopulations, including those with severe mental illness (SMI). This study examined the one-year prevalence of suicidal ideation (SI), suicide plans (SP), and suicide attempts (SA) in bipolar disorder (BD) and schizophrenia (SCZ) patients during the pandemic. Prevalence rates were compared between the two disorders and associated factors were examined. A survey was conducted in six tertiary psychiatric hospitals and psychiatric units. People with a diagnosis of BD or SCZ were invited to participate. SI, SP, and SA (suicidality for short) were assessed and associated factors were examined using binary logistical regression. The 1-year prevalence of SI, SP and SA in BD patients were 58.3%, (95% CI 54.1-62.6%), 38.4% (95% CI 34.3-42.6%) and 38.6% (95% CI 34.5-42.8%), respectively, which were higher than the corresponding figures in SCZ patients (SI 33.2%, 95% CI 28.6-37.8%; SP 16.8%, 95% CI 13.2-20.5%; SA 19.4%, 95% CI 15.5-23.3%). Patients with younger age, experience of cyberbullying, a history of SA among family or friends, a higher fatigue and physical pain score, inpatient status, and severe depressive symptoms were more likely to have suicidality. The COVID-19 pandemic was associated with increased risk of suicidality, particularly in BD patients. It is of importance to regularly screen suicidality in BD and SCZ patients during the pandemic even if they are clinically stable.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Schizophrenia
/
Suicide
/
Bipolar Disorder
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
Limits:
Humans
Language:
English
Journal:
Transl Psychiatry
Year:
2022
Document Type:
Article
Affiliation country:
S41398-022-02045-2
Similar
MEDLINE
...
LILACS
LIS